Larazotide vs Calcitonin
Head-to-head comparison of Larazotide (Larazotide acetate (AT-1001)) and Calcitonin (Salmon Calcitonin) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Larazotide | Calcitonin |
|---|---|---|
| Category | Gastrointestinal | Pain Management |
| Full Name | Larazotide acetate (AT-1001) | Salmon Calcitonin |
| Molecular Weight | N/A | 3431.9 Da |
| Half-Life | short; designed for local gut action | about 10-15 minutes |
| Amino Acids | 8 | 32 |
| Typical Dose | 0.5-4 mg TID (clinical studies) | 100 IU/day SC or 200 IU/day intranasal |
| Route | Oral | Intranasal/Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 40 | 350 |
| Research Status | Clinical | Approved |
Larazotide Benefits
- ✓tight-junction-support
- ✓reduced-permeability
- ✓symptom-reduction
- ✓barrier-protection
Calcitonin Benefits
- ✓bone pain relief
- ✓short-term analgesic effect
- ✓may reduce opioid requirement
- ✓useful in osteoporotic fracture pain
Larazotide Dosing
0.5-4 mg orally before meals in clinical trials|typically three times daily|short-course or chronic study protocols
Calcitonin Dosing
100 IU subcutaneous daily|200 IU intranasal daily|short-term use in acute pain settings
Larazotide Side Effects
- ⚠headache
- ⚠nausea
- ⚠abdominal discomfort
Calcitonin Side Effects
- ⚠nausea
- ⚠flushing
- ⚠rhinitis
Research Overview
Larazotide
Clinical and translational studies suggest larazotide can reduce antigen passage across the epithelium and improve gut barrier function. It is one of the better-known peptides for intestinal permeability and barrier-focused gastrointestinal therapy.
Calcitonin
Calcitonin has been evaluated in randomized trials and reviews for pain associated with vertebral compression fractures and other bone-related conditions. The signal is strongest for short-term analgesia rather than long-term chronic pain control.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.